A Prospective Evaluation of Radiocolloid and Immunohistochemical Staining in Colon Carcinoma Lymphatic Mapping

Cancer

Volumn 100, Issue 10, 2004, Pages 2104-2109

  Patten, Lane C ^a,b   Berger, David H ^a,b   Rodriguez Bigas, Miguel ^c   Mansfield, Paul ^c   Delpassand, Ebrahim ^c   Cleary, Karen R ^c   Fagan, Shawn P ^a,b   Curley, Steven A ^c   Hunt, Kelly K ^c   Feig, Barry W ^c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Colon carcinoma; Lymphatic mapping; Radiocolloid; Sentinel lymph node

Indexed keywords

CYTOKERATIN; ISOSULFAN BLUE; RADIOACTIVE COLLOID; RADIOISOTOPE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; COLLOID; COLON CARCINOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; LYMPH NODE METASTASIS; LYMPHATIC MAPPING; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOACTIVITY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE; STAINING; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; COLONIC NEOPLASMS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KERATINS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; ROSANILINE DYES; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 2342538993     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20233     Document Type: Article

References (23)

1. American Cancer Society. Cancer facts and figures. New York: American Cancer Society, 2001.
2. Cohen AM, Minsky BD, Schlisky RL. Cancer of the colon. In: Devita VT, Helman S, Rosenberg SA, editors. Cancer principles and practice of oncology, 5th ed. Philadelphia: Lippincott Raven, 1997:1144-1197.
3. Wong JH, Steineman S, Calderia C, Bowles J, Namiki T. Ex vivo sentinel node mapping in carcinoma of the colon and rectum. Ann Surg. 2001;233:515-521.
4. O'Connell MJ. North Central Cancer Treatment Group-Mayo Clinic Trials in colon cancer. Semin Oncol. 2001;28: 4-8.
5. Porschen R, Bermann A, Loffier T, et al. Fluorouracil plus leucovorin as effective adjuvant chemotherapy in curatively resected Stage III colon cancer: results of the trial adjCCA-01. J Clin Oncol. 2001;19:1787-1794.
6. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127:392-399.
7. Giuliano AE, Kirgen DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg. 1994;220:391-401.
8. Feig BW, Curley S, Lucci A, et al. A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg. 2001;182:707-712.
9. Tepper JE, O'Connell MJ, Niedzwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol. 2001;19:157-163.
10. Wong JH, Severino R, Honnebier B, Tom P, Namiki TS. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol. 1999;17:2896-2900.
11. Herrera-Ornelas L, Justiniano J, Castillo N, Petrelli NJ, Stulc JP, Mittelman A. Metastases in small lymph nodes from colon cancer. Arch Surg. 1987;122:1253-1256.
12. Sanchez-Maldonado W, Rodriguez-Bigas MA, Weber TK, Penetrante RB, Petrelli NJ. Utility of mapping lymph nodes cleared from rectal adenocarcinoma specimens. Surg Oncol. 1996;5:123-126.
13. Saha S, Bilchik A, Wiese D, et al. Ultrastaging of colorectal cancer by sentinel lymph node mapping technique-a multicenter trial. Ann Surg Oncol. 2001;8:94S-98S.
14. Saha S, Wiese D, Badin J, et al. Technical details of sentinel lymph node mapping in colorectal cancer and its impact on staging. Ann Surg Oncol. 2000;7:120-124.
15. Wood TF, Tsioulias GJ, Morton DL, et al. Focused examination of sentinel lymph nodes upstages early colorectal carcinoma. Am Surg. 2000;66:998-1003.
16. Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ. Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg. 1999; 86:482-486.
17. Merrie AE, van Rij AM, Phillips LV, Rossaak JI, Yun K, Mccall JL. Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum. 2001;44:410-417.
18. Tsioulias GJ, Wood TF, Spirt M, Morton DL, Bilchik AJ. A novel lymphatic mapping technique to improve localization and staging of early colon cancer during laparoscopic colectomy. Am Surg. 2002;68:561-565.
19. Greenson JK, Isenhart CE, Rice R, Mojzisik C, Houchens D, Martin EW Jr. Identification of occult micrometastases in pericolic lymph nodes of Dukes' B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Cancer. 1994;73:763-769.
20. Jeffers MD, O'Dowd GM, Mulcahy H, Stagg M, O'Donoghue DP, Toner M. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol. 1994;172:183-187.
21. Adell G, Boeryd B, Franlund B, Sjodahl R, Hakansson L. Occurrence and prognostic importance of micrometastasis in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg. 1996;162:637-642.
22. Liefers GJ, Cleton-Jansen AM, van de Velde, et al. Micrometastases and survival in Stage II colorectal cancer. N Engl J Med. 1998;339:223-228.
23. Bilchik AJ, Saha S, Wiese D, et al. Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter Phase II trial. J Clin Oncol. 2001;19:1128-1136.